Close Menu

NEW YORK – Veracyte reported after the close of the market Tuesday that its second quarter 2019 revenues grew 32 percent year over year. 

For the three months ended June 30, the genomic testing firm reported total revenues of $30.1 million compared to $22.8 million in Q2 2018, beating analysts' average estimate of $28.9 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.